- Home
- HROW vs GNL Comparison
HROW vs GNL Comparison
Compare HROW & GNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HROW
- GNL
- Stock Information
- Founded
- HROW 1998
- GNL 2011
- Country
- HROW United States
- GNL United States
- Employees
- HROW N/A
- GNL N/A
- Industry
- HROW Biotechnology: Pharmaceutical Preparations
- GNL Real Estate Investment Trusts
- Sector
- HROW Health Care
- GNL Real Estate
- Exchange
- HROW Nasdaq
- GNL Nasdaq
- Market Cap
- HROW 1.4B
- GNL 1.7B
- IPO Year
- HROW N/A
- GNL N/A
- Fundamental
- Price
- HROW $43.15
- GNL $8.08
- Analyst Decision
- HROW Strong Buy
- GNL Buy
- Analyst Count
- HROW 7
- GNL 3
- Target Price
- HROW $64.67
- GNL $8.67
- AVG Volume (30 Days)
- HROW 506.9K
- GNL 1.1M
- Earning Date
- HROW 11-12-2025
- GNL 11-05-2025
- Dividend Yield
- HROW N/A
- GNL 9.39%
- EPS Growth
- HROW N/A
- GNL N/A
- EPS
- HROW N/A
- GNL N/A
- Revenue
- HROW $227,661,000.00
- GNL $768,986,000.00
- Revenue This Year
- HROW $45.86
- GNL N/A
- Revenue Next Year
- HROW $41.41
- GNL N/A
- P/E Ratio
- HROW N/A
- GNL N/A
- Revenue Growth
- HROW 47.69
- GNL 24.38
- 52 Week Low
- HROW $20.85
- GNL $6.51
- 52 Week High
- HROW $59.23
- GNL $9.11
- Technical
- Relative Strength Index (RSI)
- HROW 69.90
- GNL 58.83
- Support Level
- HROW $38.47
- GNL $8.04
- Resistance Level
- HROW $44.07
- GNL $8.35
- Average True Range (ATR)
- HROW 1.71
- GNL 0.14
- MACD
- HROW 0.38
- GNL -0.01
- Stochastic Oscillator
- HROW 89.11
- GNL 57.03
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
About GNL Global Net Lease Inc.
Global Net Lease Inc is a real estate investment trust that manages a globally diversified portfolio of commercial real estate properties. The company is engaged in the ownership, management, operating, lease, acquisition, investment, and sale of the portfolio assets. Its segments include Industrial & Distribution; Multi-Tenant Retail; Single-Tenant Retail; and office. The company derives maximum revenue from industrial and distribution segment. The company geographically operates in Unites States, United Kingdom, Canada and Europe.